IMPLANT SITE HYPERTROPHY

This adverse event was reported 9 times

IMPLANT SITE HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTRELIN ACETATE 2 0.0023
1 ETONOGESTREL 3 0.0001
2 NYSTATIN OINTMENT 1 0.0000
3 NYSTATIN CREAM 1 0.0000
4 NYSTATIN 1 0.0000
5 ENALAPRIL 1 0.0000
6 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
7 CYCLOSPORINE 1 0.0000
8 SIMVASTATIN 1 0.0000
9 METOPROLOL TARTRATE 1 0.0000
See all drugs enriched for association with IMPLANT SITE HYPERTROPHY

These drug classes are most commonly taken by patients reporting IMPLANT SITE HYPERTROPHY:

# Drug class Count
0 Progestin [EPC] 3
1 Calcineurin Inhibitor Immunosuppressant [EPC] 1
2 HMG-CoA Reductase Inhibitor [EPC] 1
3 Polyene Antifungal [EPC] 1
See all common drug classes associated with IMPLANT SITE HYPERTROPHY

IMPLANT SITE HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Polyene Antifungal [EPC] 1 0.0000
1 Progestin [EPC] 3 0.0000
2 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
3 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE HYPERTROPHY